Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$2.22 - $6.7 $36,199 - $109,250
16,306 New
16,306 $36,000
Q4 2021

Feb 14, 2022

SELL
$11.35 - $97.17 $688,956 - $5.9 Million
-60,701 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$52.0 - $120.21 $1.15 Million - $2.65 Million
22,050 Added 57.05%
60,701 $5.56 Million
Q2 2021

Aug 13, 2021

BUY
$31.88 - $58.66 $1.23 Million - $2.27 Million
38,651 New
38,651 $2.05 Million
Q1 2021

May 17, 2021

SELL
$28.6 - $49.21 $1.02 Million - $1.75 Million
-35,556 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$27.78 - $56.93 $89,451 - $183,314
-3,220 Reduced 8.3%
35,556 $987,000
Q3 2020

Nov 16, 2020

BUY
$39.85 - $57.3 $912,764 - $1.31 Million
22,905 Added 144.32%
38,776 $1.94 Million
Q2 2020

Aug 13, 2020

BUY
$34.93 - $57.75 $439,838 - $727,188
12,592 Added 384.02%
15,871 $735,000
Q1 2020

May 15, 2020

BUY
$29.01 - $72.51 $95,123 - $237,760
3,279 New
3,279 $150,000

Others Institutions Holding CRTX

About Cortexyme, Inc.


  • Ticker CRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,150,800
  • Market Cap $70.5M
More about CRTX
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.